Clinical Study for Safety and Immunogenicity Study of Influenza Vaccine
NCT01617239
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
84
Enrollment
INDUSTRY
Sponsor class
Conditions
Influenza
Interventions
BIOLOGICAL:
Virosomal influenza vaccine
Sponsor
Crucell Holland BV